Analytical Data
-
Gene name
MORF4L2
- Application
-
Alternative Names
MORF4L2;KIAA0026;MRGX;Mortality factor 4-like Protein 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q15014
-
Expression Region
1-288aa
-
AA Sequence
MSSRKQGSQP RGQQSAEEEN FKKPTRSNMQ RSKMRGASSG KKTAGPQQKN LEPALPGRWG GRSAENPPSG SVRKTRKNKQ KTPGNGDGGS TSEAPQPPRK KRARADPTVE SEEAFKNRME VKVKIPEELK PWLVEDWDLV TRQKQLFQLP AKKNVDAILE EYANCKKSQG NVDNKEYAVN EVVAGIKEYF NVMLGTQLLY KFERPQYAEI LLAHPDAPMS QVYGAPHLLR LFVRIGAMLA YTPLDEKSLA LLLGYLHDFL KYLAKNSASL FTASDYKVAS AEYHRKAL
-
Molecular Weight
34 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MORF4L2, a member of the MORF (MORF4-related gene) family, has garnered interest in recent years due to its involvement in various biological processes, including cell proliferation and differentiation. This gene is known to encode a protein that interacts with chromatin remodeling complexes, which play essential roles in regulating gene expression, particularly in cancer cells. Research indicates that MORF4L2 may function as an oncogene, promoting tumor growth and progression in certain types of cancer, such as breast and colon cancer. Its expression levels and functional roles vary across different tissues and developmental stages, suggesting that MORF4L2 may have context-dependent effects. The study of its recombinant protein is pivotal for understanding its structure and function, as well as its potential as a therapeutic target. Advanced techniques, including recombinant DNA technology, have enabled researchers to produce MORF4L2 in a controlled laboratory setting, facilitating the investigation of its biochemical properties and interactions. Investigating MORF4L2’s role in oncogenesis could provide valuable insights into the molecular mechanisms underlying cancer, thereby contributing to the development of novel diagnostic and therapeutic strategies. In summary, the study of MORF4L2 recombinant protein is crucial for elucidating its biological significance, with implications for cancer biology and therapeutic applications.
